» Articles » PMID: 17093929

RNAi, MicroRNAs, and Human Disease

Overview
Specialty Oncology
Date 2006 Nov 10
PMID 17093929
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are short, noncoding RNAs that posttranscriptionally regulate gene expression. Over 300 miRNA genes have been identified in the human genome. We have undertaken the study of miRNA function in mammals. Using a custom microarray platform, we investigated miRNA expression patterns in mammalian development and in cancer. We found that many miRNAs are downregulated in cancer. On the other hand, several miRNA genes are overexpressed in tumor cell lines and primary tumors. Seven of these cancer-associated miRNAs are clustered in a single primary transcript termed chr13orf 25 or OncomiR-1. This cluster is located in a region amplified in lymphoma and several solid malignancies. Ectopic expression of these miRNAs in a mouse model of lymphoma accelerated disease progression. In addition, the lymphomas had reduced apoptosis and were more disseminated into secondary regions. This work establishes noncoding RNAs, and specifically miRNAs, as oncogenes in human cancers.

Citing Articles

Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.

Jayawickrama S, Ranaweera P, Pradeep R, Jayasinghe Y, Senevirathna K, Hilmi A Cancer Rep (Hoboken). 2024; 7(3):e2045.

PMID: 38522008 PMC: 10961052. DOI: 10.1002/cnr2.2045.


Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model.

Hu Y, Wang D, Zhang T, Lei M, Luo Y, Chen Z Int J Nanomedicine. 2024; 19:1809-1825.

PMID: 38414523 PMC: 10898360. DOI: 10.2147/IJN.S449042.


The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer.

Szczyrek M, Bitkowska P, Jutrzenka M, Milanowski J J Pers Med. 2022; 12(8).

PMID: 36013176 PMC: 9410235. DOI: 10.3390/jpm12081227.


Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets.

Barresi V, Musmeci C, Rinaldi A, Condorelli D Int J Mol Sci. 2022; 23(16).

PMID: 36012138 PMC: 9408055. DOI: 10.3390/ijms23168875.


MicroRNome analysis generates a blood-based signature for endometriosis.

Bendifallah S, Dabi Y, Suisse S, Jornea L, Bouteiller D, Touboul C Sci Rep. 2022; 12(1):4051.

PMID: 35260677 PMC: 8902281. DOI: 10.1038/s41598-022-07771-7.